Purchase Order 75N95019P00713
Award Date 9/24/19
Potential Completion Date 12/31/19
Potential Value $209K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lexington, MA 02421, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
- The contract award to Quanterix Corporation, a life sciences company specializing in digital biomarker detection technology, was issued by the National Institute on Drug Abuse, part of the National Institutes of Health. The $151,775.25 firm-fixed-price purchase order is for the provision of advanced instruments, assay kits, and research services to support biomedical research and diagnostic development. This contract is not designated as a set-aside. Quanterix has also been awarded an indefinite...
- The Department of Health and Human Services, National Institutes of Health awarded a firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer of goods, for the N4PA SIMOA 2.0 ASSAY KIT. The $112,969.08 award, with an October 2020 completion date, was not set aside. Quanterix has received over $30 million in prior federal contracts from agencies like the NIH, Department of Veterans Affairs, and Department of Defense to supply its ultra-sensitive digital biomarker...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract, valued at $99,653.76, is for the supply of assay kits. This award is not designated as a set-aside contract. Quanterix is the prime contractor and has not reported any major subcontractors for this award. The company has a history of federal...
- This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Quanterix Corporation. The contract, valued at $135,937.50, is for the provision of the Quanterix ELISA (Enzyme-Linked Immunosorbent Assay) System, which is used for ultra-sensitive digital biomarker detection. This contract was set aside for small businesses. Quanterix Corporation is a life sciences company specializing in advanced...
- This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract, valued at $100,500.00, is for custom assay development services. Quanterix has received over $30 million in prior federal contracts from agencies including the National Institutes of Health,...
- The National Institute of Nursing Research (NINR), a civilian agency under the National Institutes of Health (NIH), awarded a firm-fixed-price purchase order to Quanterix Corporation for $13,940.10. The award, which has no set-aside designation, is for the provision of Quanterix's ultra-sensitive digital biomarker detection technology, including Simoa (single molecule array) instruments, assay kits, and research services. Quanterix is a life sciences company specializing in advanced protein...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a firm-fixed-price purchase order contract to Quanterix Corporation, a for-profit manufacturer, to provide reagents needed to measure biological molecules in body fluids from a cohort of HIV-1 infected patients and control samples. The contract has a completion date of May 12, 2025 and a potential value of $22,519.40. This award does not include a set-aside...